Cardiac Sarcoidosis: MRI Predicts Defibrillator Benefit
- A new university of Minnesota Medical School study reveals that cardiovascular magnetic resonance imaging, or CMR phenotyping, can pinpoint cardiac sarcoidosis patients at increased risk of sudden cardiac...
- Cardiac sarcoidosis,a rare inflammatory heart disease,can lead too rhythm disturbances and heart failure.
- The study demonstrates that specific features visible on CMR scans can help doctors decide which patients should receive an ICD for primary prevention,thus refining the decision-making process for...
A groundbreaking study from the University of Minnesota reveals that cardiovascular magnetic resonance (CMR) phenotyping can accurately identify cardiac sarcoidosis patients at high risk of sudden cardiac death. This critical research, published in the european Heart Journal, offers a significant advancement, allowing doctors to better determine who will benefit from an implantable cardioverter-defibrillator (ICD). Cardiac sarcoidosis, affecting an estimated 200,000 Americans, can lead to perilous heart rhythm disturbances. This study provides a clearer method for ICD placement decisions, possibly saving lives. The innovative use of MRI scans, the primarykeyword, offers a simpler way to assess and improve patient outcomes. According to News Directory 3, this is a game changer for the accurate diagnosis of the secondarykeyword.discover how new CMR techniques are set to refine risk assessment for patients with this condition.
MRI Scans Help Identify Cardiac Sarcoidosis Patients Who Benefit from Defibrillators
A new university of Minnesota Medical School study reveals that cardiovascular magnetic resonance imaging, or CMR phenotyping, can pinpoint cardiac sarcoidosis patients at increased risk of sudden cardiac death. The research, published in the European Heart Journal, offers a more effective method for determining which patients would benefit from an implantable cardioverter-defibrillator (ICD).
Cardiac sarcoidosis,a rare inflammatory heart disease,can lead too rhythm disturbances and heart failure. It is indeed estimated to effect 200,000 Americans. For some, the condition elevates the risk of sudden cardiac arrest, which an ICD can prevent.
The study demonstrates that specific features visible on CMR scans can help doctors decide which patients should receive an ICD for primary prevention,thus refining the decision-making process for implantable defibrillators and improving patient outcomes for cardiac sarcoidosis.
Chetan shenoy, associate professor at the University of Minnesota Medical School and cardiologist with M Health Fairview, said the research offers a simpler way to identify cardiac sarcoidosis patients who are most likely to benefit from an ICD, preventing sudden cardiac death. The findings, he added, can be immediately applied in clinical practice.
Our research has developed a simpler and better way to identify which patients with suspected cardiac sarcoidosis are most likely to benefit from an implantable cardioverter-defibrillator that can prevent sudden cardiac death.
Chetan Shenoy, MBBS, MS, associate professor at the University of Minnesota Medical School
The research team advocates for CMR phenotyping to become the standard for identifying high-risk patients with suspected cardiac sarcoidosis, ensuring those most likely to benefit receive a preventive ICD. This approach to cardiac sarcoidosis aims to improve patient care and reduce the incidence of sudden cardiac death.
What’s next
Future research will focus on refining CMR phenotyping techniques and expanding its request to diverse patient populations, further improving the identification of individuals at risk of sudden cardiac death due to cardiac sarcoidosis.